PMID- 23710213 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20130528 LR - 20211021 IS - 1741-427X (Print) IS - 1741-4288 (Electronic) IS - 1741-427X (Linking) VI - 2013 DP - 2013 TI - Yueju pill rapidly induces antidepressant-like effects and acutely enhances BDNF expression in mouse brain. PG - 184367 LID - 10.1155/2013/184367 [doi] LID - 184367 AB - The traditional antidepressants have a major disadvantage in delayed onset of efficacy, and the emerging fast-acting antidepressant ketamine has adverse behavioral and neurotoxic effects. Yueju pill, an herb medicine formulated eight hundred years ago by Doctor Zhu Danxi, has been popularly prescribed in China for alleviation of depression-like symptoms. Although several clinical outcome studies reported the relative short onset of antidepressant effects of Yueju, this has not been scientifically investigated. We, therefore, examined the rapid antidepressant effect of Yueju in mice and tested the underlying molecular mechanisms. We found that acute administration of ethanol extract of Yueju rapidly attenuated depressive-like symptoms in learned helpless paradigm, and the antidepressant-like effects were sustained for at least 24 hours in tail suspension test in ICR mice. Additionally, Yueju, like ketamine, rapidly increased the expression of brain-derived neurotrophic factor (BDNF) in the hippocampus, whereas the BDNF mRNA expression remained unaltered. Yueju rapidly reduced the phosphorylation of eukaryotic elongation factor 2 (eEF2), leading to desuppression of BDNF synthesis. Unlike ketamine, both the BDNF expression and eEF2 phosphorylation were revered at 24 hours after Yueju administration. This study is the first to demonstrate the rapid antidepressant effects of an herb medicine, offering an opportunity to improve therapy of depression. FAU - Xue, Wenda AU - Xue W AD - Center for Translational Systems Biology and Neuroscience, School of Basic Biomedical Science, Nanjing University of Chinese Medicine, Nanjing 210023, China ; Laboratory of Integrative Biomedicine of Brain Diseases, School of Basic Biomedical Science, Nanjing University of Chinese Medicine, Nanjing 210023, China. FAU - Zhou, Xin AU - Zhou X FAU - Yi, Nan AU - Yi N FAU - Jiang, Lihua AU - Jiang L FAU - Tao, Weiwei AU - Tao W FAU - Wu, Runjie AU - Wu R FAU - Wang, Dan AU - Wang D FAU - Jiang, Jingjing AU - Jiang J FAU - Ge, Xiaoyin AU - Ge X FAU - Wang, Yuyue AU - Wang Y FAU - Wu, Haoxin AU - Wu H FAU - Chen, Gang AU - Chen G LA - eng PT - Journal Article DEP - 20130422 PL - United States TA - Evid Based Complement Alternat Med JT - Evidence-based complementary and alternative medicine : eCAM JID - 101215021 PMC - PMC3654702 EDAT- 2013/05/28 06:00 MHDA- 2013/05/28 06:01 PMCR- 2013/04/22 CRDT- 2013/05/28 06:00 PHST- 2013/02/19 00:00 [received] PHST- 2013/03/30 00:00 [accepted] PHST- 2013/05/28 06:00 [entrez] PHST- 2013/05/28 06:00 [pubmed] PHST- 2013/05/28 06:01 [medline] PHST- 2013/04/22 00:00 [pmc-release] AID - 10.1155/2013/184367 [doi] PST - ppublish SO - Evid Based Complement Alternat Med. 2013;2013:184367. doi: 10.1155/2013/184367. Epub 2013 Apr 22.